Kansuk Laboratuari

What Kansuk Laboratuari does

Kansuk Laboratuari is a Turkish pharmaceutical and medical device manufacturer headquartered in Arnavutköy, Turkey. Founded in 1960, the company operates with a workforce of 101-250 employees and holds GMP, ISO 13485:2016, and CE certifications, indicating it manufactures under audited quality systems suitable for both domestic Turkish distribution and regulated export markets. The combination of pharmaceutical and medical device production, together with a 65-year operating history, positions Kansuk as an established mid-sized manufacturer in the Turkish generics and medical supplies sector.

The company's competitive position is anchored by its regulatory certifications and long operational track record, which together form a compliance-led barrier to entry. It serves regulated downstream channels — hospitals, pharmacies, and distributors — through its manufacturing output, though specific product lines, therapeutic categories, and channel structure are not disclosed in the available source material. The company is privately held and does not have publicly disclosed revenue, funding, or ownership data.

The source data is materially thin: the corporate website returns only a loading/verification page, and structured fields covering products, customers, pricing, partnerships, leadership, and financials are absent. As a result, this description is limited to firmographic facts (founding year, location, headcount, certifications) and the general business-model inference that a certified pharma/medical-device manufacturer generates revenue through B2B unit sales of regulated products. Material analytical conclusions about product mix, competitive position, and growth dynamics cannot be supported by the available evidence.

Name

Kansuk Laboratuari

Website

https://kansuk.com

Company type

Private

Founded year

1960

Headcount range

101–250 employees

Short description

Kansuk Laboratuari is a Turkish pharmaceutical and medical device manufacturer founded in 1960, holding GMP, ISO 13485:2016, and CE certifications, serving regulated healthcare channels domestically and for export with 101-250 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Medical Device Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (33911)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industry

GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH)

Keywords

• Pharmaceutical manufacturing
• Medical devices
• GMP certified production
• Sterile manufacturing
• Medical product supply

Headquarters

HQ city

Arnavutköy

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure

Core offering

Kansuk Laboratuari manufactures pharmaceuticals and medical devices under regulated production conditions. Operations are certified to GMP, ISO 13485:2016, and CE standards, indicating compliance with pharmaceutical manufacturing and medical device quality system requirements. The company produces tangible medical products intended for healthcare buyers and end patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmaceutical products Manufactured pharmaceutical products produced under GMP-certified conditions, intended for healthcare providers, pharmacies, and pharmaceutical distributors serving patient populations.
• Medical devices Manufactured medical devices produced under ISO 13485:2016 quality system with CE marking compliance, intended for healthcare providers and medical device distributors.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Direct peers

• Atabay Pharmaceuticals: Turkish pharmaceutical manufacturer with GMP-certified facilities producing generics and APIs. Comparable as a domestic Turkish pharma manufacturer with similar scale and regulatory profile.
• Eczacıbaşı Pharmaceuticals (Eczacıbaşı İlaç): Established Turkish pharmaceutical manufacturer with GMP-certified production and a diversified product portfolio including generics and consumer health. Directly comparable in scale, geography, and regulated-manufacturer profile.
• Ali Raif İlaç: Turkish pharmaceutical manufacturer producing generics and branded products with GMP compliance. Highly comparable as a mid-sized domestic Turkish pharma competitor operating in overlapping therapeutic categories.
• Abdi İbrahim: Turkey's largest pharmaceutical manufacturer, producing both branded and generic drugs with GMP-certified facilities. Highly comparable to Kansuk as a domestic Turkish pharma manufacturer competing in the same product categories and regulatory framework.
• Nobel İlaç: Turkish pharmaceutical manufacturer producing generic and branded products with EU GMP certifications. Comparable in being a mid-sized Turkish pharma producer targeting both domestic and export markets.

Broad incumbents

• Viatris: Global pharmaceutical company formed from Mylan and Upjohn, focused heavily on generics and established brands with broad GMP manufacturing network. Comparable in generic-pharma manufacturing and regulatory positioning.
• Sandoz: Global leader in generic pharmaceuticals with extensive GMP-certified manufacturing footprint. Comparable as a generic-pharma manufacturer operating at scale with strong regulatory credentials, though at much larger scale.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with broad GMP-certified operations globally. Comparable in product category (generic pharmaceuticals) and regulatory compliance approach, though vastly larger in scale and geographic reach.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/100064188120461
• LinkedInlinkedin.com/company/kansuk-ilac

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kansuk Laboratuari